Dr Najoua Lalaoui
Honorary Conjoint Senior Fellow
The Sir Peter MacCallum Department of Oncology
58 Scholarly works
3 Projects
HIGHLIGHTS
2026
Journal article
Author Correction: A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activation (EMBO reports, (2023), 24, 11, (e56865), 10.15252/embr.202356865)
DOI: 10.1038/s44319-025-00609-z2026
Journal article
Inhibition of heme biosynthesis triggers cuproptosis in acute myeloid leukemia
DOI: 10.1016/j.cell.2025.10.0282025
Journal article
Divergent roles of RIPK3 and MLKL in high-fat diet–induced obesity and MAFLD in mice
DOI: 10.26508/lsa.2023024462024
Research grants (ARC, NHMRC, MRFF)
The Centre of Excellence in Autoinflammatory Disease Research
2023
Research grants (ARC, NHMRC, MRFF)
Investigating the Interplay Between Cell Death and Inflammation in Human Diseases
2018
Research Grant
Novel Therapies to Enhance Anti-Tumour Immunity
2014
Journal article
RIPK1 regulates RIPK3-MLKL-driven systemic inflammation and emergency hematopoiesis
DOI: 10.1016/j.cell.2014.04.019
RECENT SCHOLARLY WORKS
2024
Journal article
Dominant negative OTULIN-related autoinflammatory syndrome
DOI: 10.1084/jem.202221712024
Journal article
RIPK3 cleavage is dispensable for necroptosis inhibition but restricts NLRP3 inflammasome activation
DOI: 10.1038/s41418-024-01281-x2024
Journal article
Biallelic human SHARPIN loss of function induces autoinflammation and immunodeficiency
DOI: 10.1038/s41590-024-01817-w2023
Journal article
A1 is induced by pathogen ligands to limit myeloid cell death and NLRP3 inflammasome activation
DOI: 10.15252/embr.2023568652023
Conference Proceedings
Contrasting roles of necroptosis in wound recovery and skin inflammation
DOI: 10.1016/j.jid.2023.03.15382023
Journal article
RIPK3 controls MAIT cell accumulation during development but not during infection
DOI: 10.1038/s41419-023-05619-02022
Journal article
Ubiquitylation of RIPK3 beyond-the-RHIM can limit RIPK3 activity and cell death
DOI: 10.1016/j.isci.2022.104632